Gene · 6590
Papers3,867
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,867
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene expression regulation and polyadenylation in ulcerative colitis via long-chain RNA sequencing. | BMC Genomics | 2025 | 39955510 | PubTator, text mining | PubMed |
| Guizhi Shaoyao Zhimu Decoction alleviates rheumatoid arthritis by inhibiting inflammation by targeting SLPI. | Phytomedicine | 2025 | 39938174 | PubTator, text mining | PubMed |
| Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial. | Am J Respir Crit Care Med | 2025 | 39938076 | PubTator, text mining | PubMed |
| An Unusual Case of Extracavitary/Solid Variant Primary Effusion Lymphoma With Associated Hemophagocytic Lymphohistiocytosis. | J Med Cases | 2025 | 39935539 | PubTator, text mining | PubMed |
| SLPI controls neutrophil migration abilities and impacts neutrophil skin infiltration in experimental psoriasis. | Cell Mol Life Sci | 2025 | 39928132 | PubTator, text mining | PubMed |
| Divergent endothelial mechanisms drive arteriovenous malformations in Alk1 and SMAD4 loss-of-function. | bioRxiv | 2025 | 39829872 | PubTator, text mining | PubMed |
| Molecular Basis of Interchain Disulfide Bond Formation in BMP-9 and BMP-10. | J Mol Biol | 2025 | 39793884 | PubTator, text mining | PubMed |
| ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India. | Indian J Pathol Microbiol | 2025 | 39780422 | PubTator, text mining | PubMed |
| Fusion circRNA F-circEA1 facilitates EML4-ALK1 positive lung adenocarcinoma progression through the miR-4673/SMAD4/ADAR1 axis. | Cell Signal | 2025 | 39710092 | PubTator, text mining | PubMed |
| Hereditary Hemorrhagic Telangiectasia: On the Brink of a New Treatment Era? | Semin Thromb Hemost | 2025 | 39694043 | PubTator, text mining | PubMed |
| A benchmarked, high-efficiency prime editing platform for multiplexed dropout screening. | Nat Methods | 2025 | 39562753 | PubTator, text mining | PubMed |
| Modeling Drug Responses and Evolutionary Dynamics Using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple-Negative Breast Cancer. | Cancer Res | 2025 | 39514406 | PubTator, text mining | PubMed |
| Elucidating the Role of Autophagy-related Genes in Polycystic Ovary Syndrome: Implications for Diagnostic Models and Immune Response Regulation. | Curr Med Chem | 2025 | 39421991 | PubTator, text mining | PubMed |
| Behçet's disease modifies the gingival inflammatory response. | J Periodontol | 2025 | 39295442 | PubTator, text mining | PubMed |
| Evaluation of AAV Capsids and Delivery Approaches for Hereditary Hemorrhagic Telangiectasia Gene Therapy. | Transl Stroke Res | 2025 | 38977637 | PubTator, text mining | PubMed |
| Exploration of immune cell heterogeneity by single-cell RNA sequencing and identification of secretory leukocyte protease inhibitor as an oncogene in pancreatic cancer. | Environ Toxicol | 2025 | 38476085 | PubTator, text mining | PubMed |
| Mechanistic insights into HPV-positivity in non-smokers and HPV-negativity in smokers with head and neck cancer. | Front Oncol | 2024 | 39850816 | PubTator, text mining | PubMed |
| Urinary Immune Complexes Reflect Renal Pathology in Lupus Nephritis. | Diagnostics (Basel) | 2024 | 39767148 | PubTator, text mining | PubMed |
| Machine learning-based selection of immune cell markers in osteosarcoma: prognostic determination and validation of CLK1 in disease progression. | Front Immunol | 2024 | 39742274 | PubTator, text mining | PubMed |
| Primary gastric T-cell lymphoma presenting with perforation: a case report and review of the literature. | J Hematop | 2024 | 39738732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6590/papers?page=7